Lixisenatide
- 47 trials, 19 with no results posted
- 39 of 47 trials sponsored by its developers
- Humans2
Trials
47Approved
31 Jan 2013WithdrawnDiabetes Mellitus, Type 2
27 Jul 2016
Repurposing
Phase 4Completed5 trials
Phase 3Results posted3 trials
Phase 3Results posted8 trials
Phase 3Results posted1 trial
Phase 4Completed1 trial
Phase 4Completed1 trial
All 7Fewer
Phase 2Completed1 trial
Stopped
NCT02767596TerminatedType 2 diabetes
Insufficient recruitment rate
Trial sponsors
Company36 trialsPhase 420,206 people
Profil Institut für Stoffwechselforschung
Company1 trialPhase 1109 people
1 trialPhase 41,316 people
1 trialPhase 4100 people
1 trialPhase 440 people
Hospital Universitari Vall d'Hebron Research Institute
1 trialPhase 440 people
1 trialPhase 418 people
1 trialPhase 48 people
Latest
8 in 12 monthsFoot & Ankle Specialist
Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis
Cohort study of 8,117 peopleOsteoarthritis
medRxiv
Neuro-Adverse Events Associated with GLP-1 Receptor Agonists: A Study Based on the FAERS Database and External Validation Using NHANES Database
Preprint: cohort study of 17,057 peopleGLP-1 receptor agonists
AHA Scientific Sessions 2025 Abstract
Targeting Cerebrovascular Risk in Diabetes: GLP-1 Receptor Agonists as Neuroprotective Agents
ReviewInterventions
AHA Scientific Sessions 2025 Abstract
Polygenic Modification of Weight Loss Response to GLP-1 Receptor Agonists
Study in peopleInterventions
AHA Scientific Sessions 2025 Abstract
Use Of Glucagon Like Peptide 1 Receptor Agonists In Non Diabetic Patients With Dilated Cardiomyopathy
Study in peopleInterventions
AHA Scientific Sessions 2025 Abstract
GLP-1 Receptor Agonists and Clinical Outcomes in Non-Diabetic Patients with Peripartum Cardiomyopathy: A Propensity-Matched Retrospective Cohort Study
Study in peopleInterventions
ADA Scientific Sessions 2025 Abstract
Association between Preoperative GLP-1RA Use and Postoperative Respiratory Complications in Real-World Patients Undergoing Elective Surgical Procedures—A Target Trial Emulation Study
Study in peoplePopulations
The Lancet Diabetes & Endocrinology
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Meta-analysis of randomised trialsGLP-1 receptor agonists